The molecular mechanisms mediating morphogenesis during mammalian embryogenesis are poorly understood. In part this is related to the fact that few mammalian genes known to control specific aspects of morphogenetic development have been cloned and characterized. The recent development of techniques to insert new genetic information into the mouse genome and to create transgenic mice provides a new methodology to simultaneously mutate and molecularly tag mammalian genes. The major goal of the research proposed herein is to develop a vector system that significantly simplifies the search for, and maintenance of, transgenic mice with developmental disorders caused by insertional mutagenesis.
The specific aims are 1) to develop a visual identification system (VlS) vector that will permit hemizygous and homozygous transgenic mice to be identified and distinguished by simple visual inspection, and then to sue the vector to generate new families of transgenic mice which will be screened for insertional developmental mutations; 2) to use the VIS vector to evaluate the frequency of integration by homologous recombination in microinjected mouse embryos; and 3) to use the VIS vector to evaluate the frequency of integration by gap repair in microinjected mouse embryos. The VIS vector to be tested contains a lens-specific crystallin promotor linked to a truncated, non-tumorigenic, SV40 early region. The vector will be tested for dominant induction of cataract formation, an easily identifiable visual phenotype. The downless gene will be the target for the homologous recombination experiments and the OTCase gene will be used for the gap repair experiments. The identification by insertional mutagenesis of mammalians that play specific roles in development, and the improvement of techniques for gene-specific mutagenesis in mammalian organisms are important steps toward a better understanding of the molecular basis for mammalian embryogenesis and, morphogenesis. Such studies can have important implications for treatment of human infertility and prevention of human birth defects.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD025340-04
Application #
3326471
Study Section
Special Emphasis Panel (SRC (04))
Project Start
1989-04-01
Project End
1993-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Chevez-Barrios, P; Schaffner, D L; Barrios, R et al. (1993) Expression of the rasT24 oncogene in the ciliary body pigment epithelium and retinal pigment epithelium results in hyperplasia, adenoma, and adenocarcinoma. Am J Pathol 143:20-8
Yokoyama, T; Copeland, N G; Jenkins, N A et al. (1993) Reversal of left-right asymmetry: a situs inversus mutation. Science 260:679-82
Schaffner, D L; Barrios, R; Massey, C et al. (1993) Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol 142:1051-60
MacGregor, G R; Overbeek, P A (1991) Use of a simplified single-site PCR to facilitate cloning of genomic DNA sequences flanking a transgene integration site. PCR Methods Appl 1:129-35
Overbeek, P A; Aguilar-Cordova, E; Hanten, G et al. (1991) Coinjection strategy for visual identification of transgenic mice. Transgenic Res 1:31-7
Russell, L D; Hikim, A P; Overbeek, P A et al. (1991) Testis structure in the sys (symplastic spermatids) mouse. Am J Anat 192:169-82
Yokoyama, T; Silversides, D W; Waymire, K G et al. (1990) Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res 18:7293-8
MacGregor, G R; Russell, L D; Van Beek, M E et al. (1990) Symplastic spermatids (sys): a recessive insertional mutation in mice causing a defect in spermatogenesis. Proc Natl Acad Sci U S A 87:5016-20